Regulus Therapeutics Inc. (RGLS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.58

-0.32%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Revenue	-	-	-	10.01M	6.83M	72.00K	72.00K	1.19M	20.76M	7.67M	19.57M	12.70M	13.79M	8.60M
Cost of Revenue	21.15M	122.00K	459.00K	15.35K	12.35K	33.98M	54.59M	64.31M	56.39M	41.05M	29.94M	20.34K	-	-
Gross Profit	-21.15M	-122.00K	-459.00K	9.99M	6.82M	-33.90M	-54.52M	-63.11M	-35.63M	-33.38M	-10.37M	12.68M	13.79M	8.60M
Operating Income	-31.11M	-28.24M	-27.82M	-14.15M	-16.83M	-46.76M	-70.13M	-81.50M	-54.76M	-44.91M	-17.80M	-12.57M	-7.14M	-15.50M
Interest Income	1.68M	605.00K	864.00K	233.00K	374.00K	459.00K	752.00K	844.00K	855.00K	388.00K	292.00K	110.00K	128.00K	271.00K
Pretax Income	-30.04M	-28.32M	-27.81M	-15.73M	-18.59M	-48.65M	-72.10M	-81.84M	-55.77M	-56.68M	-18.69M	-17.42M	-7.40M	-15.59M
Net Income	-30.04M	-28.32M	-27.81M	-15.26M	-18.59M	-48.71M	-71.91M	-81.84M	-55.75M	-56.68M	-18.67M	-17.41M	-7.60M	-15.56M
Selling & General & Admin	9.96M	9.83M	10.02M	8.81M	11.32M	12.86M	17.01M	18.39M	19.13M	11.53M	7.43M	4.93M	3.64M	3.92M
Research & Development	21.15M	18.41M	17.79M	15.35M	12.35M	33.98M	53.19M	64.31M	56.39M	41.05M	29.94M	20.34M	17.29M	20.18M
Other Expenses	-21.15M	-83.00K	9.00K	-1.57M	-1.76M	-1.88M	-	-	-	-	-	-	3.64M	3.92M
Operating Expenses	9.96M	28.24M	27.82M	24.16M	23.67M	46.84M	70.20M	82.70M	75.52M	52.58M	37.37M	25.27M	20.93M	24.10M
Interest Expense	604.00K	688.00K	855.00K	1.81M	2.13M	2.34M	2.72M	1.18M	52.00K	39.00K	36.00K	247.00K	388.00K	362.00K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	31.11M	28.24M	27.82M	24.16M	23.67M	46.84M	70.20M	82.70M	75.52M	52.58M	37.37M	25.27M	20.93M	24.10M
Income Tax	1K	1K	1K	-467.00K	1K	62.00K	-197.00K	-4.00K	-18.00K	1K	-23.00K	-10.00K	206.00K	-30.00K
Shares Outstanding (Basic)	18.96M	15.26M	8.57M	3.50M	1.73M	871.86K	626.92K	440.11K	428.43K	367.42K	320.66K	68.44K	2.14K	2.14K
Shares Outstanding (Diluted)	18.96M	15.26M	8.57M	3.50M	1.73M	871.86K	626.92K	440.11K	428.43K	367.42K	320.66K	68.44K	2.14K	2.14K
EPS (Basic)	-1.58	-1.86	-3.24	-4.36	-10.77	-55.87	-114.7	-185.94	-130.12	-154.27	-58.22	-254.37	-3.55K	-7.27K
EPS (Diluted)	-1.58	-1.86	-3.24	-4.36	-10.77	-55.87	-114.7	-185.94	-130.12	-154.27	-58.22	-254.37	-3.55K	-7.27K
EBITDA	-30.88M	-28.12M	-27.36M	-13.46M	-15.53M	-44.04M	-66.86M	-78.38M	-54.12M	-55.15M	-17.30M	-16.15M	-6.10M	-14.73M
Depreciation & Amortization	227.00K	122.00K	459.00K	467.00K	931.00K	2.26M	2.52M	2.28M	1.59M	1.49M	1.36M	1.02M	911.00K	494.00K